Search Results

There are 16944 results for: content related to: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

  1. You have free access to this content
    Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

    Arthritis & Rheumatism

    Volume 50, Issue 11, November 2004, Pages: 3432–3443, E. William St. Clair, Désirée M. F. M. van der Heijde, Josef S. Smolen, Ravinder N. Maini, Joan M. Bathon, Paul Emery, Edward Keystone, Michael Schiff, Joachim R. Kalden, Ben Wang, Kimberly DeWoody, Roberta Weiss, Daniel Baker and Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group

    Version of Record online : 4 NOV 2004, DOI: 10.1002/art.20568

  2. Infliximab for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell and Maria Angeles Lopez-Olivo

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD003785

  3. You have free access to this content
    Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 56, Issue 7, July 2007, Pages: 2129–2134, A. E. van der Bijl, Y. P. M. Goekoop-Ruiterman, J. K. de Vries-Bouwstra, S. ten Wolde, K. H. Han, M. V. van Krugten, C. F. Allaart, F. C. Breedveld and B. A. C. Dijkmans

    Version of Record online : 28 JUN 2007, DOI: 10.1002/art.22718

  4. You have free access to this content
    Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 118–128, David Ternant, Emilie Ducourau, Aleth Perdriger, Anca Corondan, Benoît Le Goff, Valérie Devauchelle-Pensec, Elisabeth Solau-Gervais, Hervé Watier, Philippe Goupille, Gilles Paintaud and Denis Mulleman

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12313

  5. Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 673–683, T. Billiet, I. Cleynen, V. Ballet, M. Ferrante, G. Van Assche, A. Gils and S. Vermeire

    Version of Record online : 9 AUG 2016, DOI: 10.1111/apt.13754

  6. You have free access to this content
    The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 46, Issue 6, June 2002, Pages: 1451–1459, E. William St.Clair, Carrie L. Wagner, Adedigbo A. Fasanmade, Benjamin Wang, Thomas Schaible, Arthur Kavanaugh and Edward C. Keystone

    Version of Record online : 6 JUN 2002, DOI: 10.1002/art.10302

  7. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Version of Record online : 17 JUN 2011, DOI: 10.1002/pds.2132

  8. You have free access to this content
    A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 56, Issue 9, September 2007, Pages: 3096–3106, Nicolino Ruperto, Daniel J. Lovell, Ruben Cuttica, Nick Wilkinson, Patricia Woo, Graciela Espada, Carine Wouters, Earl D. Silverman, Zsolt Balogh, Michael Henrickson, Maria-Teresa Apaz, Eileen Baildam, Anders Fasth, Valeria Gerloni, Pekka Lahdenne, Anne-Marie Prieur, Angelo Ravelli, Rotraud K. Saurenmann, Maria Luz Gamir, Nico Wulffraat, Laszlo Marodi, Ross E. Petty, Rik Joos, Francesco Zulian, Deborah McCurdy, Barry L. Myones, Kalman Nagy, Peter Reuman, Ilona Szer, Suzanne Travers, Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini and Edward H. Giannini

    Version of Record online : 30 AUG 2007, DOI: 10.1002/art.22838

  9. You have free access to this content
    Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1357–1363, M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett and P. J. Hamlin

    Version of Record online : 6 OCT 2010, DOI: 10.1111/j.1365-2036.2010.04482.x

  10. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 801–810, Mihaela Ringheanu, Fredric Daum, James Markowitz, Jeremiah Levine, Seymour Katz, Xingyu Lin and Jack Silver

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00015

  11. You have free access to this content
    Review article: infliximab therapy for inflammatory bowel disease – seven years on

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 4, February 2006, Pages: 451–463, P. RUTGEERTS, G. VAN ASSCHE and S. VERMEIRE

    Version of Record online : 20 JAN 2006, DOI: 10.1111/j.1365-2036.2006.02786.x

  12. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  13. You have free access to this content
    Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

    Arthritis & Rheumatism

    Volume 52, Issue 4, April 2005, Pages: 1227–1236, Christian E. Antoni, Arthur Kavanaugh, Bruce Kirkham, Zuhre Tutuncu, Gerd R. Burmester, Udo Schneider, Daniel E. Furst, Jerry Molitor, Edward Keystone, Dafna Gladman, Bernhard Manger, Siegfried Wassenberg, Ralf Weier, Daniel J. Wallace, Michael H. Weisman, Joachim R. Kalden and Josef Smolen

    Version of Record online : 7 APR 2005, DOI: 10.1002/art.20967

  14. You have free access to this content
    Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

    British Journal of Clinical Pharmacology

    Volume 73, Issue 1, January 2012, Pages: 55–65, David Ternant, Denis Mulleman, Francine Lauféron, Céline Vignault, Emilie Ducourau, Daniel Wendling, Philippe Goupille and Gilles Paintaud

    Version of Record online : 8 DEC 2011, DOI: 10.1111/j.1365-2125.2011.04050.x

  15. You have free access to this content
    Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis

    Scandinavian Journal of Immunology

    Volume 78, Issue 3, September 2013, Pages: 275–284, R. Dahlén, H. Strid, A. Lundgren, S. Isaksson, S. Raghavan, M. K. Magnusson, M. Simrén, H. Sjövall and L. Öhman

    Version of Record online : 22 AUG 2013, DOI: 10.1111/sji.12081

  16. Infliximab

    Dermatologic Therapy

    Volume 17, Issue 5, October 2004, Pages: 409–426, Laura S. Winterfield and Alan Menter

    Version of Record online : 20 SEP 2004, DOI: 10.1111/j.1396-0296.2004.04044.x

  17. You have free access to this content
    Review article: the practical management of acute severe ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 4, February 2016, Pages: 482–513, D. Seah and P. De Cruz

    Version of Record online : 4 JAN 2016, DOI: 10.1111/apt.13491

  18. Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

    The Journal of Clinical Pharmacology

    Volume 48, Issue 6, June 2008, Pages: 681–695, Zhenhua Xu, Kathleen Seitz, Adedigbo Fasanmade, Joyce Ford, Paul Williamson, Weichun Xu, Hugh M. Davis and Honghui Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008316886

  19. You have free access to this content
    Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

    Arthritis & Rheumatism

    Volume 50, Issue 4, April 2004, Pages: 1051–1065, R. N. Maini, F. C. Breedveld, J. R. Kalden, J. S. Smolen, D. Furst, M. H. Weisman, E. W. St.Clair, G. F. Keenan, D. van der Heijde, P. A. Marsters and P. E. Lipsky

    Version of Record online : 5 APR 2004, DOI: 10.1002/art.20159

  20. You have free access to this content
    Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 3, August 2009, Pages: 210–226, G. R. LICHTENSTEIN, R. H. DIAMOND, C. L. WAGNER, A. A. FASANMADE, A. D. OLSON, C. W. MARANO, J. JOHANNS, Y. LANG and W. J. SANDBORN

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1365-2036.2009.04027.x